Evidence map›Paper›PMID 37333569›Full record

ArticleOTO open

Office-Based Blue Laser Therapy for Vocal Fold Leukoplakia: A Preliminary Report of 12 Cases.

Abdul-Latif Hamdan, Anthony Ghanem, Patrick Abou Raji Feghali, Jad Hosri, Christophe Abi Zeid Daou, Samer Abou-Rizk

Open access · goldAbstract read
In one paragraph

Article in OTO open. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 9 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Vocal Folds' Oscillatory Characteristics After Photoangiolytic Laser Treatment Using the Blue Light Laser-A Pilot Study.Journal of otolaryngology - head & neck surgery = Le Journal d'oto-rhino-laryngologie et de chirurgie cervico-faciale
    Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Abdul-Latif HamdanDepartment of Otolaryngology and Head & Neck Surgery American University of Beirut Medical Center Beirut Lebanon.ORCID 0000-0003-1493-3568
Anthony GhanemDepartment of Otolaryngology and Head & Neck Surgery American University of Beirut Medical Center Beirut Lebanon.ORCID 0000-0002-8965-3619
Patrick Abou Raji FeghaliDepartment of Otolaryngology and Head & Neck Surgery American University of Beirut Medical Center Beirut Lebanon.ORCID 0000-0002-2827-1289
Jad HosriDepartment of Otolaryngology and Head & Neck Surgery American University of Beirut Medical Center Beirut Lebanon.ORCID 0000-0002-7781-3486
Christophe Abi Zeid DaouDepartment of Otolaryngology and Head & Neck Surgery American University of Beirut Medical Center Beirut Lebanon.ORCID 0000-0001-9706-0066
Samer Abou-RizkDepartment of Otolaryngology and Head & Neck Surgery Lebanese American University Medical Center-Rizk Hospital Beirut Lebanon.ORCID 0000-0003-1619-2898
American University of Beirut Medical Center · LBUniversity Medical Center Rizk Hospital · LB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: To report the efficacy of office-based blue laser therapy for vocal fold leukoplakia. Study Design: A retrospective case series. Setting: A tertiary care center. Methods: A retrospective chart review of patients with vocal fold leukoplakia who underwent office-based blue laser therapy between July 2019 and October 2022 was conducted. The video recordings of their laryngeal examination and their voice evaluation were analyzed before and after surgical intervention. Results: A total of 10 patients, eight with unilateral disease and 2 with bilateral disease, were included in this study. In total, 12 vocal folds with leukoplakia were treated. Nine had a single session and 3 had 2 sessions due to incomplete regression of the lesion after the first laser therapy session. Following treatment, 9 regressed completely (75%) and 3 regressed partially (25%). The mean Voice Handicap Index-10 (VHI-10) score decreased significantly from 15.4 ± 12.9 preoperatively to 3.8 ± 2.86 after surgery ( Conclusion: This preliminary study indicates that office-based blue laser therapy is an effective treatment modality for vocal fold leukoplakia.

Indexed as

blue laserdysphoniaoffice‐basedvocal fold leukoplakia

Identifiers

PMID37333569
PMCPMC10272296
OpenAlexW4380992255

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.